Evidence-based dry-eye therapies for clinical use
8 October 2021
Volume 22, Issue 3
This article outlines a range of dry-eye disease management strategies available at each severity level and between subtypes of the disease.
Domains covered
Professionalism
Clinical practice
Specialty CPD (IP)
Despite recent advances in the management and treatment of dry-eye disease, the condition is still managed differently across continents and countries. From diagnosis to disease progression and treatment, patients should be well informed about the safe and effective use of available therapies. Consequently, this article aims to appraise eye care practitioners of a wide range of management strategies available at each severity level and between subtypes of dry-eye disease.
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
This online peer review session is open to College members and will cover your GOC peer review requirement. It is worth three interactive CPD points.
In this live webinar, Patrick Gunn will talk about what to look out for when examining the optic disc and explain how to use technology effectively to support the management of glaucoma suspects.
How do clinicians choose between generic and branded drugs, balancing the need for patient safety against cost? Kathy Oxtoby takes a look.